China Immunotech (beijing) Biotechnology Co., Ltd.

This early-stage study is testing whether a new cell therapy called YTS109 is safe and might help adults with autoimmune hemolytic anemia who have not improved after trying at least three other treatments. Researchers will give patients different doses of the modified cells to fi…